GRI Bio GRI Cash Flow Statement (2020-2026)

NASDAQ GRI
$2.00 -0.10 (-4.76%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

GRI Bio Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

GRI Bio reported cash from operations of -$1.45M and free cash flow of -$1.45M for the quarter ended Jun 2026, up 54.3% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M-1.65M
Depreciation and Depletion
0.02M0.02M0.02M-0.02M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Share-based Compensation
0.13M0.19M0.18M-0.18M0.03M0.01M0.01M0.33M0.04M0.04M0.04M0.04M0.04M0.22M0.04M0.47M0.07M0.03M0.03M
Cash from Operations
-1.29M-1.58M-2.29M2.17M-0.12M-0.84M-0.58M-1.54M-1.31M-5.56M-2.20M-2.14M-2.27M-2.00M-1.74M-3.17M-2.31M-2.97M-3.69M-1.45M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.02M0.02M0.02M-0.02M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in Account Payables
-0.40M0.42M0.32M-0.24M-0.00M0.82M0.41M3.77M0.68M-2.70M-0.74M0.34M0.25M-0.24M0.33M0.04M0.02M0.27M-1.51M0.22M
Change in Accured Expenses
0.04M0.70M-0.23M0.63M0.18M0.11M-0.04M1.19M-0.05M-0.98M-0.17M-0.08M-0.39M0.16M0.56M-0.29M0.43M-0.64M-0.32M0.10M
Other Working Capital Changes
-0.17M-0.16M-0.04M0.02M-0.01M-0.01M-0.03M0.78M0.09M-0.29M-0.56M0.19M0.05M0.01M-0.20M0.06M-0.13M0.01M-0.10M0.16M
Investing Activities
Capital Expenditures
0.00M
Cash from Investing Activities
-3.27M-0.58M1.15M-1.15M-0.00M-0.01M
Financing Activities
Other financing activities
0.01M0.10M0.04M
Debt Issuance and Repayment
Long-Term Debt Issuances
0.12M1.12M1.25M
Long-Term Debt Repayments
0.02M0.02M0.02M0.02M-0.03M0.11M
Change in Capital Stock
Net Equity Issued and Repurchased
-0.40M0.01M5.50M-5.50M0.00M0.76M0.94M-5.94M6.82M1.40M
Misc.
Cash from Financing Activities
-0.02M-0.02M-0.02M0.06M0.22M0.75M1.03M5.89M3.88M4.49M4.40M0.66M2.28M-0.01M5.01M1.25M7.15M6.50M1.34M
Change in Cash
-4.58M-2.18M-1.16M1.08M0.10M-0.10M0.45M4.34M-1.31M-1.68M2.28M2.26M-1.61M0.28M-1.75M1.84M-1.07M4.17M2.82M-0.10M
Free Cash Flow
-1.29M-1.58M-2.29M2.17M-0.12M-0.85M-0.58M-1.54M-1.31M-5.56M-2.20M-2.14M-2.27M-2.00M-1.74M-3.17M-2.31M-2.97M-3.69M-1.45M
Net Cash Flow
-4.58M-2.18M-1.16M1.08M0.10M-0.10M0.45M4.34M-1.31M-1.68M2.28M2.26M-1.61M0.28M-1.75M1.84M-1.07M4.18M2.82M-0.10M

GRI Bio Cash Flow Statement API

Pull GRI Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GRI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY